Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C T DOLLERY

Showing results (201-210 of 212) with videos related to

Pageof 22
Sort By:
British Medical Journal|April 21, 1979
Comparison of black and white patients attending hypertension clinics in EnglandA D Munro-Faure, L J Beilin, C J Bulpitt, et al.
Prostaglandins|February 1, 1984
Synthesis of leukotriene B4, and prostanoids by human alveolar macrophages: analysis by gas chromatography/mass spectrometryJ MacDermot, C R Kelsey, K A Waddell, et al.
British Medical Journal (Clinical Research Ed.)|March 27, 1982
Hydralazine, antinuclear antibodies, and the lupus syndromeR Mansilla-Tinoco, S J Harland, P J Ryan, et al.
Journal of Hypertension|September 1, 1995
Alcohol intake and cardiovascular mortality in hypertensive patients: report from the Department of Health Hypertension Care Computing ProjectA J Palmer, A E Fletcher, C J Bulpitt, et al.
Clinical Pharmacology and Therapeutics|March 1, 1976
Maternal and neonatal elimination of amobarbital after treatment of the mother with barbiturates during late pregnancyG H Draffan, C T Dollery, D S Davies, et al.
Lancet (London, England)|July 21, 1979
Risk factors for death in treated hypertensive patients. Report from the D.H.S.S. Hypertension Care Computing ProjectC J Bulpitt, L J Beilin, P Clifton, et al.
British Heart Journal|January 1, 1980
Long-term antihypertensive drug treatment and blood pressure control in three hospital hypertension clinicsL J Beilin, C J Bulpitt, E C Coles, et al.
British Journal of Clinical Pharmacology|December 1, 1979
Reduction of circulating 25-hydroxyvitamin D by antipyrineP F Wilmana, M J Brodie, J C Mucklow, et al.
Lancet (London, England)|May 24, 1980
Hydralazine-induced systemic lupus erythematosus: influence of HLA-DR and sex on susceptibilityJ R Batchelor, K I Welsh, R M Tinoco, et al.
Lancet (London, England)|September 23, 1997
Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial InvestigatorsJ A Staessen, R Fagard, L Thijs, et al.
Pageof 22

Showing results (201-210 of 212) with videos related to

Sort By:
Pageof 22
British Medical Journal|April 21, 1979
Comparison of black and white patients attending hypertension clinics in EnglandA D Munro-Faure, L J Beilin, C J Bulpitt, et al.
Prostaglandins|February 1, 1984
Synthesis of leukotriene B4, and prostanoids by human alveolar macrophages: analysis by gas chromatography/mass spectrometryJ MacDermot, C R Kelsey, K A Waddell, et al.
British Medical Journal (Clinical Research Ed.)|March 27, 1982
Hydralazine, antinuclear antibodies, and the lupus syndromeR Mansilla-Tinoco, S J Harland, P J Ryan, et al.
Journal of Hypertension|September 1, 1995
Alcohol intake and cardiovascular mortality in hypertensive patients: report from the Department of Health Hypertension Care Computing ProjectA J Palmer, A E Fletcher, C J Bulpitt, et al.
Clinical Pharmacology and Therapeutics|March 1, 1976
Maternal and neonatal elimination of amobarbital after treatment of the mother with barbiturates during late pregnancyG H Draffan, C T Dollery, D S Davies, et al.
Lancet (London, England)|July 21, 1979
Risk factors for death in treated hypertensive patients. Report from the D.H.S.S. Hypertension Care Computing ProjectC J Bulpitt, L J Beilin, P Clifton, et al.
British Heart Journal|January 1, 1980
Long-term antihypertensive drug treatment and blood pressure control in three hospital hypertension clinicsL J Beilin, C J Bulpitt, E C Coles, et al.
British Journal of Clinical Pharmacology|December 1, 1979
Reduction of circulating 25-hydroxyvitamin D by antipyrineP F Wilmana, M J Brodie, J C Mucklow, et al.
Lancet (London, England)|May 24, 1980
Hydralazine-induced systemic lupus erythematosus: influence of HLA-DR and sex on susceptibilityJ R Batchelor, K I Welsh, R M Tinoco, et al.
Lancet (London, England)|September 23, 1997
Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial InvestigatorsJ A Staessen, R Fagard, L Thijs, et al.
Pageof 22